Finance

Lists
Why is 301230 up 14.22%?
Dive Deeper
301230:SHE
PharmaResources (Shanghai) Co Ltd
CN¥36.71
+14.22%
(+4.57) 1D
Oct 16, 3:04:58 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301230...
Open
CN¥34.39
High
CN¥38.57
Low
CN¥34.02
Mkt. cap
6.20B
Avg. vol.
16.40M
Volume
39.46M
Dividend
0.78%
Quarterly dividend
CN¥0.07
Ex-dividend date
Jul 16, 2026
P/E ratio
175.26
52-wk high
CN¥52.28
52-wk low
CN¥22.23
EPS
CN¥0.21
Shares outstanding
180.94M
No. of employees
1K
Open
CN¥34.39
High
CN¥38.57
Low
CN¥34.02
Mkt. cap
6.20B
Avg. vol.
16.40M
Volume
39.46M
Dividend
0.78%
Quarterly dividend
CN¥0.07
Ex-dividend date
Jul 16, 2026
P/E ratio
175.26
52-wk high
CN¥52.28
52-wk low
CN¥22.23
EPS
CN¥0.21
Shares outstanding
180.94M
No. of employees
1K
News stories
From web sources and news partners
About PharmaResources (Shanghai) Co Ltd
CEO-
Employees1.3K
FoundedDec 14, 2007
Headquarters-
SectorHealth care
Websitepharmaresources.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
161.66M
173.95M
172.29M
192.12M
Cost of goods sold
113.37M
141.40M
117.29M
154.67M
Cost of revenue
113.37M
141.40M
117.29M
154.67M
Research and development expenses
9.80M
8.36M
10.74M
10.16M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26.90M
31.02M
27.59M
28.57M
Operating expense
37.54M
41.00M
38.16M
41.06M
Total operating expenses
150.91M
182.40M
155.45M
195.73M
Operating income
10.75M
-8.45M
16.83M
-3.61M
Other non operating income
1.57M
-1.69M
-2.12M
2.05M
EBT including unusual items
9.15M
-3.51M
25.98M
4.15M
EBT excluding unusual items
8.67M
-11.07M
19.90M
-2.44M
Income tax expense
-840.10K
-3.05M
2.21M
-800.39K
Effective tax rate
-9.18%
87.04%
8.49%
-19.29%
Other operating expenses
896.06K
306.17K
327.40K
312.57K
Net income
9.99M
-454.81K
23.78M
4.95M
Net profit margin
6.18%
-0.26%
13.80%
2.58%
Earnings per share
-
-
-
-
Interest and investment income
288.09K
177.60K
7.10M
5.13M
Interest expense
-2.04M
-1.98M
-1.91M
-1.77M
Net interest expenses
-1.75M
-1.80M
5.18M
3.35M
Depreciation and amortization charges
-
-
-
-
EBITDA
17.23M
-1.39M
23.90M
3.89M
Gain or loss from assets sale
-
-41.52K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps